Myasthenia Gravis: all 327 studies
Page 3 of 4. Open to participants first (144), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of HN2301 in Refractory Myasthenia Gravis(MG)TerminatedNCT06965309Not applicable
- The Safety and Efficacy of S103 in the Treatment of Refractory Generalized Myasthenia GravisActive, not recruitingNCT06958939Phase 1
- A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune DiseasesWithdrawnNCT06869278Phase 1
- Artificial Intelligence for the Analysis of Video Data of Facial Movement, with a Focus on Myasthenia GravisCompletedNCT06860360
- Biomarkers for Fatigue in Patients with Myasthenia GravisCompletedNCT06860347
- Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia GravisActive, not recruitingNCT06799247Phase 3
- Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Eculizumab in Chinese Adults With gMGCompletedNCT06764160Phase 3
- A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia GravisActive, not recruitingNCT06744920Phase 3
- Cognitive Functioning in People With Myasthenia Graivs: Impact on Daily Life Activities, Work, Disability and Quality of LifeCompletedNCT06718855
- Characteristics and Prognostic Outcomes of Diaphragmatic Ultrasound in Myasthenia GravisActive, not recruitingNCT06707727
- Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia GravisActive, not recruitingNCT06704269Phase 1/2
- A Study in Patients With Myasthenia Gravis in ChinaActive, not recruitingNCT06700616
- Interventions Against Fatigue in Patients With Myasthenia GravisActive, not recruitingNCT06659627Not applicable
- Interval Inspiratory Training and Aerobic Exercise for Muscle Recovery in Myasthenia Gravis Post-HospitalizationCompletedNCT06624345Not applicable
- A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia GravisActive, not recruitingNCT06558279Phase 3
- An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia GravisActive, not recruitingNCT06540144Phase 3
- A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.Active, not recruitingNCT06517758Phase 3
- Pilot Study: Use of the Saccadometer to Detect Characteristic Saccadic Peak Velocity in Myasthenia Gravis PatientsCompletedNCT06501794Not applicable
- A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)Active, not recruitingNCT06456580Phase 3
- Efficacy and Safety of Sugammadex in Thoracoscopy Thymectomy for Chinese Adults With Myasthenia GravisCompletedNCT06436768Not applicable
- An Exploratory Clinical Study of GC012F Injection for Refractory gMGWithdrawnNCT06419166Early Phase 1
- Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-AssessmentCompletedNCT06381284
- A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)Active, not recruitingNCT06282159Phase 2
- Medlink for Diagnosing of Diabetes Mellitus, COPD, CHF, Myasthenia Gravis and HypertensionCompletedNCT06256172Not applicable
- A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)Active, not recruitingNCT06220201Phase 1
- Investigation of the Effects of Proprioceptive Neuromuscular Facilitation Exercises in Patients With Myasthenia GravisCompletedNCT06158815Not applicable
- A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia GravisCompletedNCT06149559Phase 2/3
- Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia GravisActive, not recruitingNCT06106672Phase 1/2
- Univent Tube for Thoracoscopic Thymectomy in Myasthenic PatientsCompletedNCT06101407
- Exploring Outcomes and Characteristics of Myasthenia Gravis 2CompletedNCT06002945
- Digital Phenotyping and Lifestyle Intervention in Patients with Myasthenia GravisCompletedNCT05992025Not applicable
- Yogic Breathing Exercise for People With Amyotrophic Lateral SclerosisCompletedNCT05979688Not applicable
- Exploring Accessible Beauty for Individuals With Upper Extremity DeficitsCompletedNCT05945784
- The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia GravisCompletedNCT05917184
- The Risk of Falls Index for Patients With Neuromuscular DisordersCompletedNCT05890833
- Study of Telitacicept in Generalized Myasthenia GravisCompletedNCT05737160Phase 3
- Influences of Sugammadex on Postoperative Progress in Patients With Myasthenia Gravis Undergoing Video-assisted Thoracoscopic Thymectomy: Retrospective StudyCompletedNCT05694234
- Evaluation of PK, PD, Efficacy, Safety, and Immunogenicity of IV Ravulizumab in Pediatric Participants With Generalized Myasthenia GravisActive, not recruitingNCT05644561Phase 3
- Descriptive Analysis of Real-world Data Collected with ME&MGopenCompletedNCT05566964
- Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia GravisActive, not recruitingNCT05556096Phase 3
- A Prospective, Single-Center Investigation of the da Vinci SP® Surgical System in Anterior Mediastinal DiseaseActive, not recruitingNCT05455840Not applicable
- Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia GravisCompletedNCT05451212Phase 1
- Exercise in Autoimmune Myasthenia Gravis and Myasthenic SyndromesCompletedNCT05408702
- Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia GravisTerminatedNCT05403541Phase 3
- Association Study Between VDR Gene Polymorphisms and Risk and Features of MG in Han Chinese PopulationCompletedNCT05380128
- Efficacy and Safety of Low-dose Rituximab in the Treatment of Refractory Myasthenia GravisStatus unknownNCT05332587Phase 3
- Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia GravisCompletedNCT05332210Phase 3
- Diaphragm Thickness by Ultrasonography in Neurological DisordersCompletedNCT05324176Not applicable
- Interleukin and Autoantibodies in Myasthenia Gravis.Status unknownNCT05301153
- Comparison of Single Port and Two Ports Robotic Assisted Thoracic Surgery for ThymectomyStatus unknownNCT05262582Not applicable
- The Specificity, Sensitivity and Clinical Correlation of CBA, RIPA and ELISA in Detecting AChR and MuSK IgG of Myasthenia GravisCompletedNCT05219097
- Immune Profiles in Myasthenia GravisStatus unknownNCT05095103
- Study on Correlation Between Cytomegalovirus and Ocular Myasthenia GravisStatus unknownNCT05091177
- A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia GravisActive, not recruitingNCT05070858Phase 3
- Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia GravisCompletedNCT05045248Phase 2
- Evaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG PatientsCompletedNCT05039190Phase 3
- Study of ALXN1830 Administered Subcutaneously in Adults With Generalized Myasthenia GravisWithdrawnNCT04982289Phase 2
- Oxaloacetate in Myasthenia GravisWithdrawnNCT04965987Phase 1
- Safety and Efficacy of Inactivated SARS-CoV-2 Vaccine in Immune-related Myopathy (Myasthenia Gravis and Inflammatory Myopathy) Patients ：a Prospective Observational StudyStatus unknownNCT04941079
- Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia GravisStatus unknownNCT04768465
- Subcutaneous Immunoglobulin for Myasthenia GravisCompletedNCT04728425Phase 2
- Follow-up of a Cohort of Patients With Myasthenic Syndrome and COVID-19 InfectionCompletedNCT04695379
- A Prospective Cohort Study Of Myasthenia GravisStatus unknownNCT04674605
- Ocular Mysathenia Gravis GeneralizationCompletedNCT04667650
- Help Build an A.I. Model to Predict Myasthenia Gravis Symptom Patterns and FlaresCompletedNCT04590716
- Medication Adherence and Non-adherence in Adults With Rare DiseaseWithdrawnNCT04541875
- Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot StudyCompletedNCT04431895Early Phase 1
- A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG PatientsCompletedNCT04346888Phase 2
- Study of Pyridostigmine With Ondansetron in Subjects With Anti-AchR Positive Myasthenia GravisTerminatedNCT04226170Phase 2
- Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia GravisCompletedNCT04225871Phase 3
- A Pilot Study to Explore the Role of Gut Flora in Myasthenia GravisWithdrawnNCT04224506
- The Impact of Myasthenia Gravis in the Real WorldCompletedNCT04176211
- Influence of Minimally Invasive Thymectomy on the Subsequent Clinical Course of Myasthenia GravisStatus unknownNCT04158661
- Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)Active, not recruitingNCT04146051Phase 2
- Clinical Prognosis and Progression of Myasthenia Gravis PatientsStatus unknownNCT04101578
- A Non-Interventional Pilot Study to Explore the Role of Gut Flora in DiseaseSuspendedNCT04031469
- Burden of Disease in Myasthenia GravisCompletedNCT03979521
- Spontaneous Coronary Artery Dissection (SCAD) and AutoimmunityCompletedNCT03941184
- Beta-agonist Efficacy and Tolerability as Adjuvant Therapy in Myasthenia GravisStatus unknownNCT03914638Phase 2/3
- Physical Activity and Fatigue in Myasthenia GravisCompletedNCT03905473
- Rhythmic Auditory Stimulation and Walking Speed in the 6-minute Walk TestCompletedNCT03905161
- Can Interval Walking Influence on Fatigue in the Danish Cohort of Myasthenia Gravis PatientsWithdrawnNCT03900585Not applicable
- Incidence and Risk of Influenza in Myasthenic PatientsCompletedNCT03884777
- Neurology Inpatient Clinical Education TrialCompletedNCT03826056Not applicable
- Transsternal Versus Transcervical ThymectomyCompletedNCT03825185Not applicable
- The Effect of Spinal Stabilization Exercises in Patients With Myasthenia GravisCompletedNCT03743740Not applicable
- The Curative Effect of Extended Thymectomy Performed Through Subxiphoid-right VATS Approach With Elevation of SternumStatus unknownNCT03613272Not applicable
- Variables Predicting Reintubation After Thymectomy in Patients With Myasthenia GravisStatus unknownNCT03597373
- Effect of Pyridostigmine (Mestinon) on Muscle Strength in Myasthenia GravisStatus unknownNCT03510546Phase 4
- Early Versus Late Extubation in Myasthenia Gravis PatientsCompletedNCT03468452
- Myasthenia Gravis and PsycheCompletedNCT03205306
- A Study to Evaluate the Efficacy of CV-MG01 (Myasterix) in Myasthenia GravisWithdrawnNCT03165435Phase 2/3
- Trial of Orencia in Patients With Myasthenia GravisTerminatedNCT03059888Early Phase 1
- OVEMP in MyastheniaCompletedNCT03049956Not applicable
- Tissue Repository for Studies of Myasthenia GravisCompletedNCT02902536
- A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG)CompletedNCT02774239Phase 3
- Biomarkers in Neural DisordersCompletedNCT02761707
- Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia GravisCompletedNCT02609022Phase 1/2
- Translation, Cross-cultural Adaptation and Validation of the MGQOL-15-FCompletedNCT02470364
- The Safety and Efficacy of "3-Hole" Subxiphorid Approach in the Treatment of Anterior Mediastinal TumorStatus unknownNCT02317224Phase 2